Jump to content
Powered by

Hartmann continues to grow profitably

Heidenheim-based Hartmann Group further accelerated its growth in the first six months of 2008. The company reports a growth in sales revenues to 678.5 million euros (up 7.4%) and increased its consolidated operating net income by 22.1% to 22.5 million euros.

Significant impetus for this growth came from the Operating Theatre Management, Wound Management and Incontinence Management segments, in which revenues rose by 8.5% over the last year. The greatest growth was achieved by the Operating Theatre Management segment where sales revenues rose 13.8% to 105.8 million. Sales in the Wound Management segment rose 8.4% to 204.4 million euros. In the Incontinence Management segment, sales revenues rose 6.5% to 252.4 million euros compared to the same period last year.

Outlook: further growth

On 30 June 2008, the share of the medical core segments in total sales was 83%. In the current fiscal year, Hartmann expects “considerable above-market sales growth” in the medical core segments.

The Hartmann Group is a collection of 18 German and 65 foreign subsidiaries of Paul Hartmann AG. The company has subsidiaries in 35 countries and has approximately 9,000 employees. More than 50% of the company’s revenues are generated in Europe, and one-third in Germany alone.

The Schwenk Group, headquartered in Ulm, became the majority shareholder of the Hartmann Group in January 2008. The Group, which is the leading manufacturer of building materials, is owned by Eduard Schleicher who is a relative of the Merckle family.

Source: Hartmann AG press release - 15 August 2008/4 February 2008 (P, wp, 20 August 2008)
Website address: https://www.gesundheitsindustrie-bw.de/en/article/news/hartmann-continues-to-grow-profitably